2009 Fiscal Year Final Research Report
Enhancing effect in the expression of tumor antigens and T-cell sensitivity against tumor cells after treatment with epigenetic drugs.
Project/Area Number |
20790930
|
Research Category |
Grant-in-Aid for Young Scientists (B)
|
Allocation Type | Single-year Grants |
Research Field |
General surgery
|
Research Institution | Shimane University |
Principal Investigator |
HARASHIMA Nanae Shimane University, 医学部, 助教 (60345311)
|
Project Period (FY) |
2008 – 2009
|
Keywords | 腫瘍 / 免疫 / エピジェネティクス / 薬剤反応性 |
Research Abstract |
Histone deacetylase inhibitor (HDACi) strikingly induced cell death and decreasing cell viability of the human renal cell carcinoma and prostate cancer cells in dose- and time-dependent manner, although the effect of a DNA methyltransferase inhibitor was not recognized. Moreover, tumor-specific antigens were maintained their gene expression as a target of T-cells which enough recognizes the cancer cells after HDACi treatment.
|
-
-
-
[Journal Article] Impaired Tax-specific T-cell responses with insufficient control of HTLV-1 in a subgroup of individuals at asymptomatic and smoldering stages.2009
Author(s)
Shimizu Y, Takamori A, Utsunomiya A, Kurimura M, Yamano Y, Hishizawa M, Hasegawa A, Kondo F, Kurihara K, Harashima N, Watanabe T, Okamura J, Masuda T, Kannagi M
-
Journal Title
Cancer Sci. 100
Pages: 481-489
Peer Reviewed
-
[Journal Article] ( *These authors contributed equally to this work. ) Regression of human kidney cancer following allogeneic stem cell transplantation is associated with recognition of an HERV-E antigen by T cells.2008
Author(s)
Takahashi Y*, Harashima N*, Kajigaya S, Yokoyama H, Cherkasova E, McCoy JP, Hanada K, Mena O, Kurlander R, Tawab A, Srinivasan R, Lundqvist A, Malinzak E, Geller N, Lerman MI, Childs RW
-
Journal Title
J Clin Invest. 118
Pages: 1099-1109
Peer Reviewed
-
-
-
-
-
-
-
-
-
-